Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
Abstract Voriconazole is the cornerstone of the treatment and prevention of fungal infections. While there is a good correlation between CYP2C19 genotype and voriconazole exposure during prophylactic treatment, no correlation was found in patients with invasive aspergillosis. Proinflammatory cytokin...
Saved in:
Main Authors: | Sylvia D. Klomp (Author), Anette Veringa (Author), Jan‐Willem C. Alffenaar (Author), Mark G. J. deBoer (Author), Lambert F. R. Span (Author), Henk‐Jan Guchelaar (Author), Jesse J. Swen (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterisation of <it>CYP2C8</it>, <it>CYP2C9 </it>and <it>CYP2C19 </it>polymorphisms in a Ghanaian population
by: Dodoo Alexander NO, et al.
Published: (2009) -
Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in iranian hematological patients
by: Sholeh Ebrahimpour, et al.
Published: (2017) -
Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations
by: Sara Flores-Gutiérrez, et al.
Published: (2017) -
The impact of CYP2C19 genotype on phenoconversion by concomitant medication
by: Laura M. de Jong, et al.
Published: (2023) -
Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis
by: Jing Ling, et al.
Published: (2024)